Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 137

1.

Evolution, controversies and the future of prostate cancer grading.

Egevad L, Delahunt B, Yaxley J, Samaratunga H.

Pathol Int. 2019 Feb;69(2):55-66. doi: 10.1111/pin.12761. Epub 2019 Jan 29. Review.

PMID:
30694570
2.

Grading of renal cell carcinoma.

Delahunt B, Eble JN, Egevad L, Samaratunga H.

Histopathology. 2019 Jan;74(1):4-17. doi: 10.1111/his.13735. Review.

PMID:
30565310
3.

Datasets for the reporting of neoplasia of the testis: recommendations from the International Collaboration on Cancer Reporting.

Berney DM, Comperat E, Feldman DR, Hamilton RJ, Idrees MT, Samaratunga H, Tickoo SK, Yilmaz A, Srigley JR.

Histopathology. 2019 Jan;74(1):171-183. doi: 10.1111/his.13736. Review.

PMID:
30565308
4.

The current status of renal cell carcinoma and prostate carcinoma grading.

Delahunt B, Egevad L, Yaxley J, Samaratunga H.

Int Braz J Urol. 2018 Nov-Dec;44(6):1057-1062. doi: 10.1590/S1677-5538.IBJU.2018.06.01. No abstract available.

5.

Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker.

Sina AA, Carrascosa LG, Liang Z, Grewal YS, Wardiana A, Shiddiky MJA, Gardiner RA, Samaratunga H, Gandhi MK, Scott RJ, Korbie D, Trau M.

Nat Commun. 2018 Dec 4;9(1):4915. doi: 10.1038/s41467-018-07214-w.

6.

MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature.

Pokorny M, Kua B, Esler R, Yaxley J, Samaratunga H, Dunglison N, Gianduzzo T, Coughlin G, Holt R, Laing B, Ault D, Brown N, Parkinson R, Thompson L.

World J Urol. 2018 Sep 25. doi: 10.1007/s00345-018-2497-y. [Epub ahead of print]

PMID:
30255394
7.

Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.

Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Coughlin G, Dunglison N, Gianduzzo T, Kua B, Malone G, Martin B, Preston J, Pokorny M, Wood S, Samaratunga H.

Histopathology. 2019 Jan;74(2):284-290. doi: 10.1111/his.13737. Epub 2018 Oct 17.

PMID:
30129659
8.

Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction.

Koo KM, Wang J, Richards RS, Farrell A, Yaxley JW, Samaratunga H, Teloken PE, Roberts MJ, Coughlin GD, Lavin MF, Mainwaring PN, Wang Y, Gardiner RA, Trau M.

ACS Nano. 2018 Aug 28;12(8):8362-8371. doi: 10.1021/acsnano.8b03698. Epub 2018 Jul 26.

PMID:
30028592
9.

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study.

Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, Teloken P, Dunglison N, Williams S, Lavin MF, Gardiner RA.

Lancet Oncol. 2018 Aug;19(8):1051-1060. doi: 10.1016/S1470-2045(18)30357-7. Epub 2018 Jul 17.

PMID:
30017351
10.

Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?

Ng KL, Del Vecchio SJ, Samaratunga H, Morais C, Rajandram R, Vesey DA, Wood ST, Gobe GC.

Pathology. 2018 Aug;50(5):504-510. doi: 10.1016/j.pathol.2018.01.007. Epub 2018 Jun 30.

PMID:
29970253
11.

Re: Comment on Egevad et al., 'Utility of Pathology Imagebase for standardisation of prostate cancer grading'.

Egevad L, Samaratunga H, Delahunt B.

Histopathology. 2018 Aug;73(2):361-362. doi: 10.1111/his.13637. Epub 2018 May 30. No abstract available.

PMID:
29672898
12.

Utility of Pathology Imagebase for standardisation of prostate cancer grading.

Egevad L, Delahunt B, Berney DM, Bostwick DG, Cheville J, Comperat E, Evans AJ, Fine SW, Grignon DJ, Humphrey PA, Hörnblad J, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, Magi-Galluzzi C, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, True LD, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M.

Histopathology. 2018 Jul;73(1):8-18. doi: 10.1111/his.13471. Epub 2018 Mar 5.

PMID:
29359484
13.

Fuhrman grading is inappropriate for papillary renal cell carcinoma.

Delahunt B, Egevad L, Srigley JR, Samaratunga H.

World J Urol. 2018 Aug;36(8):1335-1336. doi: 10.1007/s00345-017-2153-y. Epub 2017 Dec 18. No abstract available.

PMID:
29256019
14.

Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.

Egevad L, Delahunt B, Kristiansen G, Samaratunga H, Varma M.

Pathology. 2018 Jan;50(1):60-73. doi: 10.1016/j.pathol.2017.09.008. Epub 2017 Dec 6. Review.

PMID:
29199015
15.

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.

Yaxley JW, Dagher J, Delahunt B, Egevad L, Srigley J, Samaratunga H.

World J Urol. 2018 Jan;36(1):15-20. doi: 10.1007/s00345-017-2119-0. Epub 2017 Nov 7.

PMID:
29116393
16.

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

Kristiansen A, Drevin L, Delahunt B, Samaratunga H, Robinson D, Franck Lissbrant I, Stattin P, Egevad L.

Pathology. 2017 Dec;49(7):715-720. doi: 10.1016/j.pathol.2017.08.008. Epub 2017 Oct 14.

PMID:
29037803
17.

The decline of medical publishing: the rise of the pseudo-journal.

Delahunt B, Samaratunga H, Egevad L.

Pathology. 2017 Dec;49(7):673-674. doi: 10.1016/j.pathol.2017.08.001. Epub 2017 Sep 23. No abstract available.

PMID:
28950991
18.

A novel technique for biobanking of large sections of radical prostatectomy specimens.

Lindh C, Delahunt B, Samaratunga H, Yaxley J, Gudjónsdóttir J, Clements M, Lindberg J, Egevad L.

Histopathology. 2018 Feb;72(3):481-489. doi: 10.1111/his.13386. Epub 2017 Nov 21.

PMID:
28881048
19.

Pathology Imagebase-a reference image database for standardization of pathology.

Egevad L, Cheville J, Evans AJ, Hörnblad J, Kench JG, Kristiansen G, Leite KRM, Magi-Galluzzi C, Pan CC, Samaratunga H, Srigley JR, True L, Zhou M, Clements M, Delahunt B; ISUP Pathology Imagebase Expert Panel.

Histopathology. 2017 Nov;71(5):677-685. doi: 10.1111/his.13313. Epub 2017 Sep 13.

PMID:
28722802
20.

Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.

Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Srigley JR, Coughlin G, Dunglinson N, Gianduzzo T, Kua B, Malone G, Martin B, Preston J, Pokorny M, Wood S, Yaxley J, Samaratunga H.

Histopathology. 2017 Dec;71(6):918-925. doi: 10.1111/his.13311. Epub 2017 Oct 2.

PMID:
28718911

Supplemental Content

Loading ...
Support Center